Therapeutic lipid-coated hybrid nanoparticles against bacterial infections

One of the most important health concerns in society is the development of pathogen-causing nosocomial infections. Since the first discovery of antibiotics, bacterial infections have been highly treatable. However, with evolution and the nondiscretionary usage of antibiotics, pathogens have also fou...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiang, Lai, Lee, Hiang Wee, Loo, Joachim Say Chye
Other Authors: School of Materials Science and Engineering
Format: Article
Language:English
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/10356/144245
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-144245
record_format dspace
spelling sg-ntu-dr.10356-1442452023-07-14T16:01:02Z Therapeutic lipid-coated hybrid nanoparticles against bacterial infections Jiang, Lai Lee, Hiang Wee Loo, Joachim Say Chye School of Materials Science and Engineering Engineering::Materials Biofilms Nanoparticles One of the most important health concerns in society is the development of pathogen-causing nosocomial infections. Since the first discovery of antibiotics, bacterial infections have been highly treatable. However, with evolution and the nondiscretionary usage of antibiotics, pathogens have also found new ways to survive the onslaught of antibiotics by surviving intracellularly or through the formation of obstinate biofilms, and through these, the outcomes of regular antibiotic treatments may now be unsatisfactory. Lipid-coated hybrid nanoparticles (LCHNPs) are the next-generation core-shell structured nanodelivery system, where an inorganic or organic core, loaded with antimicrobials, is enveloped by lipid layers. This core-shell structure, with multifarious decorations, not only improves the loading capabilities of therapeutics but also have the potential to improve therapeutic delivery, especially for targeting biofilm-based and intracellular bacterial infections. Although there have been significant interests in the development of LCHNPs, they have yet to be widely exploited for bacterial infections. In this review, we will provide an overview on the latest development of LCHNPs and the various approaches in synthesizing this nano-delivery system. In addition, a discussion on future perspectives of LCHNPs, in combination with other novel anti-bacterial technologies, will be provided towards the end of this review. Ministry of Education (MOE) Published version The authors would like to acknowledge the financial support from the Singapore Centre for Environmental Life Sciences Engineering (SCELSE) (MOE/RCE: M4330019.C70), Ministry of Education AcRF-Tier 1 grant (RG19/18), Agri-Food & Veterinary Authority of Singapore (APF LCK102), Biomedical Research Council (BMRC) – Therapeutics Development Review (TDR-G-004-001), NTU-HSPH grant (NTU-HSPH 17002), and the Bill and Melinda Gates Foundation (OPP1199116). 2020-10-22T05:35:22Z 2020-10-22T05:35:22Z 2020 Journal Article Jiang, L., Lee, H. W., & Loo, J. S. C. (2020). Therapeutic lipid-coated hybrid nanoparticles against bacterial infections. RSC Advances, 10, 8497-8517. doi:10.1039/C9RA10921H 2046-2069 https://hdl.handle.net/10356/144245 10.1039/C9RA10921H 10 8497 8517 en RSC Advances © 2020 The Royal Society of Chemistry. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering::Materials
Biofilms
Nanoparticles
spellingShingle Engineering::Materials
Biofilms
Nanoparticles
Jiang, Lai
Lee, Hiang Wee
Loo, Joachim Say Chye
Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
description One of the most important health concerns in society is the development of pathogen-causing nosocomial infections. Since the first discovery of antibiotics, bacterial infections have been highly treatable. However, with evolution and the nondiscretionary usage of antibiotics, pathogens have also found new ways to survive the onslaught of antibiotics by surviving intracellularly or through the formation of obstinate biofilms, and through these, the outcomes of regular antibiotic treatments may now be unsatisfactory. Lipid-coated hybrid nanoparticles (LCHNPs) are the next-generation core-shell structured nanodelivery system, where an inorganic or organic core, loaded with antimicrobials, is enveloped by lipid layers. This core-shell structure, with multifarious decorations, not only improves the loading capabilities of therapeutics but also have the potential to improve therapeutic delivery, especially for targeting biofilm-based and intracellular bacterial infections. Although there have been significant interests in the development of LCHNPs, they have yet to be widely exploited for bacterial infections. In this review, we will provide an overview on the latest development of LCHNPs and the various approaches in synthesizing this nano-delivery system. In addition, a discussion on future perspectives of LCHNPs, in combination with other novel anti-bacterial technologies, will be provided towards the end of this review.
author2 School of Materials Science and Engineering
author_facet School of Materials Science and Engineering
Jiang, Lai
Lee, Hiang Wee
Loo, Joachim Say Chye
format Article
author Jiang, Lai
Lee, Hiang Wee
Loo, Joachim Say Chye
author_sort Jiang, Lai
title Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
title_short Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
title_full Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
title_fullStr Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
title_full_unstemmed Therapeutic lipid-coated hybrid nanoparticles against bacterial infections
title_sort therapeutic lipid-coated hybrid nanoparticles against bacterial infections
publishDate 2020
url https://hdl.handle.net/10356/144245
_version_ 1773551315199197184